A Dose-Escalation Study of MDX-010 Administered Monthly as Immunotherapy in Subjects Infected With Human Immunodeficiency Virus (HIV)
Condition(s):Human Immunodeficiency Virus (HIV)Last Updated:January 23, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Human Immunodeficiency Virus (HIV)Last Updated:January 23, 2018Completed
Condition(s):Advanced MelanomaLast Updated:June 20, 2014Completed
Condition(s):Advanced MelanomaLast Updated:January 6, 2014Completed
Condition(s):MelanomaLast Updated:June 9, 2014Completed
Condition(s):Clostridium InfectionsLast Updated:February 9, 2021Completed
Condition(s):MelanomaLast Updated:November 2, 2014Completed
Condition(s):MelanomaLast Updated:March 2, 2010Completed
Condition(s):MelanomaLast Updated:September 28, 2016Completed
Condition(s):Synovial SarcomaLast Updated:October 12, 2022Terminated
Condition(s):Malignant MelanomaLast Updated:September 28, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.